A
AptaBio Therapeutics Inc
KOSDAQ:293780
AptaBio Therapeutics Inc
KOSDAQ:293780
Price:
7 700
KRW
-3.02%
Market Closed
Market Cap:
₩207B
Cash Flow Statement
Cash Flow Statement
AptaBio Therapeutics Inc
AptaBio Therapeutics Inc
Currency: KRW
| Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||||||||||||||
| Net Income |
(4 063)
|
(5 146)
|
(4 399)
|
(6 636)
|
(6 298)
|
(5 445)
|
(5 038)
|
(3 830)
|
(3 919)
|
(6 133)
|
(7 906)
|
(10 388)
|
(10 689)
|
(10 132)
|
(11 437)
|
(10 339)
|
(1 868)
|
(636)
|
(2 792)
|
(19 098)
|
(18 596)
|
(23 477)
|
(27 334)
|
(29 336)
|
(27 948)
|
(25 143)
|
(20 184)
|
|
| Depreciation & Amortization |
10
|
11
|
17
|
38
|
75
|
122
|
165
|
199
|
224
|
241
|
258
|
269
|
320
|
343
|
394
|
448
|
40
|
43
|
42
|
500
|
491
|
485
|
479
|
476
|
482
|
476
|
470
|
|
| Stock-Based Compensation |
382
|
502
|
624
|
977
|
489
|
0
|
501
|
145
|
181
|
72
|
83
|
122
|
138
|
137
|
134
|
0
|
69
|
77
|
0
|
187
|
244
|
261
|
452
|
234
|
233
|
244
|
287
|
|
| Other Non-Cash Items |
1 399
|
1 345
|
634
|
124
|
101
|
(480)
|
(1 499)
|
(1 665)
|
(1 424)
|
(102)
|
(400)
|
880
|
(90)
|
(29)
|
1 785
|
929
|
83
|
(948)
|
(860)
|
3 258
|
3 492
|
8 085
|
10 538
|
8 692
|
7 289
|
4 358
|
1 905
|
|
| Cash Taxes Paid |
8
|
18
|
23
|
55
|
89
|
129
|
98
|
104
|
101
|
123
|
(2)
|
4
|
9
|
5
|
(16)
|
(17)
|
(14)
|
17
|
45
|
48
|
67
|
98
|
100
|
76
|
63
|
(95)
|
(135)
|
|
| Cash Interest Paid |
0
|
0
|
1
|
1
|
4
|
4
|
4
|
4
|
4
|
5
|
4
|
4
|
2
|
2
|
0
|
0
|
3
|
6
|
9
|
11
|
11
|
11
|
11
|
10
|
10
|
9
|
9
|
|
| Change in Working Capital |
905
|
1 431
|
528
|
2 605
|
121
|
292
|
1 035
|
(160)
|
1 333
|
1 389
|
1 522
|
1 085
|
1 562
|
1 153
|
2 241
|
2 272
|
96
|
(428)
|
2 305
|
1 244
|
1 143
|
(854)
|
318
|
8 009
|
3 928
|
5 646
|
2 432
|
|
| Cash from Operating Activities |
(1 749)
N/A
|
(2 360)
-35%
|
(3 221)
-37%
|
(3 869)
-20%
|
(6 002)
-55%
|
(5 511)
+8%
|
(5 338)
+3%
|
(5 455)
-2%
|
(3 785)
+31%
|
(4 605)
-22%
|
(6 525)
-42%
|
(8 155)
-25%
|
(8 897)
-9%
|
(8 664)
+3%
|
(7 016)
+19%
|
(6 689)
+5%
|
(1 650)
+75%
|
(1 969)
-19%
|
(1 305)
+34%
|
(14 095)
-980%
|
(13 469)
+4%
|
(15 761)
-17%
|
(16 000)
-2%
|
(12 160)
+24%
|
(16 250)
-34%
|
(14 662)
+10%
|
(15 377)
-5%
|
|
| Investing Cash Flow | ||||||||||||||||||||||||||||
| Capital Expenditures |
(28)
|
(109)
|
(1 234)
|
(1 613)
|
(3 740)
|
(3 914)
|
(3 060)
|
(5 048)
|
(2 076)
|
(1 880)
|
(1 619)
|
760
|
(169)
|
(206)
|
(659)
|
(785)
|
50
|
462
|
446
|
(167)
|
0
|
(64)
|
76
|
(240)
|
(277)
|
(279)
|
(292)
|
|
| Other Items |
(7 656)
|
(7 144)
|
(41 244)
|
(47 193)
|
(40 794)
|
(47 828)
|
1 692
|
4 925
|
2 448
|
7 483
|
4 442
|
9 496
|
1 302
|
10 162
|
5 264
|
1 714
|
(732)
|
1 178
|
(18 093)
|
(12 570)
|
(15 635)
|
(1 991)
|
14 503
|
13 094
|
9 547
|
(939)
|
3 061
|
|
| Cash from Investing Activities |
(7 684)
N/A
|
(7 252)
+6%
|
(42 478)
-486%
|
(48 806)
-15%
|
(44 534)
+9%
|
(51 742)
-16%
|
(1 368)
+97%
|
(123)
+91%
|
372
N/A
|
5 603
+1 408%
|
2 823
-50%
|
10 257
+263%
|
1 133
-89%
|
9 956
+779%
|
4 605
-54%
|
930
-80%
|
(682)
N/A
|
1 640
N/A
|
(17 647)
N/A
|
(12 737)
+28%
|
(15 754)
-24%
|
(2 055)
+87%
|
14 579
N/A
|
12 854
-12%
|
9 270
-28%
|
(1 218)
N/A
|
2 769
N/A
|
|
| Financing Cash Flow | ||||||||||||||||||||||||||||
| Net Issuance of Common Stock |
10 857
|
0
|
66 400
|
66 400
|
66 400
|
67 251
|
851
|
1 492
|
1 492
|
0
|
0
|
0
|
19
|
608
|
608
|
608
|
0
|
0
|
11 100
|
11 102
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
0
|
(4)
|
(9)
|
(15)
|
(19)
|
(20)
|
(21)
|
(23)
|
(23)
|
(23)
|
(25)
|
(27)
|
(38)
|
(48)
|
(63)
|
(81)
|
(17)
|
(26)
|
38 869
|
38 772
|
38 771
|
38 769
|
(132)
|
(134)
|
(136)
|
(640)
|
(650)
|
|
| Other |
64
|
156
|
(3 566)
|
(3 566)
|
(3 567)
|
(3 617)
|
40
|
40
|
40
|
(3)
|
0
|
(42)
|
(356)
|
(357)
|
(357)
|
(317)
|
(2)
|
(5)
|
(14)
|
(19)
|
(19)
|
(19)
|
(23)
|
(33)
|
(33)
|
(32)
|
(21)
|
|
| Cash from Financing Activities |
10 921
N/A
|
11 009
+1%
|
62 825
+471%
|
62 820
0%
|
62 814
0%
|
63 614
+1%
|
870
-99%
|
1 509
+73%
|
1 508
0%
|
615
-59%
|
614
0%
|
(69)
N/A
|
(376)
-444%
|
203
N/A
|
188
-7%
|
210
+11%
|
(608)
N/A
|
(620)
-2%
|
49 366
N/A
|
49 854
+1%
|
49 854
0%
|
49 852
0%
|
(154)
N/A
|
(167)
-9%
|
(169)
-1%
|
(671)
-298%
|
(671)
+0%
|
|
| Change in Cash | ||||||||||||||||||||||||||||
| Effect of Foreign Exchange Rates |
15
|
23
|
12
|
28
|
12
|
22
|
13
|
(6)
|
(10)
|
(18)
|
(14)
|
3
|
20
|
16
|
33
|
51
|
4
|
(11)
|
(34)
|
5
|
10
|
19
|
(5)
|
(1)
|
(14)
|
(25)
|
(11)
|
|
| Net Change in Cash |
1 504
N/A
|
1 420
-6%
|
17 138
+1 107%
|
10 172
-41%
|
12 290
+21%
|
6 384
-48%
|
(5 823)
N/A
|
(4 075)
+30%
|
(1 916)
+53%
|
1 595
N/A
|
(3 102)
N/A
|
2 036
N/A
|
(8 120)
N/A
|
1 511
N/A
|
(2 190)
N/A
|
(5 498)
-151%
|
(2 937)
+47%
|
(960)
+67%
|
30 380
N/A
|
23 027
-24%
|
20 641
-10%
|
32 056
+55%
|
(1 579)
N/A
|
525
N/A
|
(7 162)
N/A
|
(16 576)
-131%
|
(13 290)
+20%
|
|
| Free Cash Flow | ||||||||||||||||||||||||||||
| Free Cash Flow |
(1 777)
N/A
|
(2 469)
-39%
|
(4 455)
-80%
|
(5 482)
-23%
|
(9 742)
-78%
|
(9 424)
+3%
|
(8 397)
+11%
|
(10 503)
-25%
|
(5 862)
+44%
|
(6 485)
-11%
|
(8 144)
-26%
|
(7 394)
+9%
|
(9 066)
-23%
|
(8 870)
+2%
|
(7 675)
+13%
|
(7 474)
+3%
|
(1 600)
+79%
|
(1 507)
+6%
|
(860)
+43%
|
(14 263)
-1 559%
|
(13 469)
+6%
|
(15 825)
-17%
|
(15 923)
-1%
|
(12 400)
+22%
|
(16 527)
-33%
|
(14 941)
+10%
|
(15 669)
-5%
|
|
Switch to:
Switch to:
See Also
Discover More
